Impact

Philly Just Ranked High on a Global List of Startup Ecosystems. These Local Leaders Aren’t Surprised

September 23, 2021

A report assessing the strengths, talent and startup resources of regions around the globe this year named Philadelphia in its top 30 ecosystems. The city moved up 15 spots in the Startup Genome’s Global Startup Ecosystem Report (GSER) after being named the top “emerging” ecosystem last year. For 2021, it’s No. 28 on the global […]

Read More

Philadelphia’s Startup Ecosystem Climbs 15 Spots Into the Top 30 Worldwide, Report Says

September 22, 2021

Philadelphia’s startup ecosystem ranks among the best in the world, reaching No. 28 globally, according to the latest report from research firm Startup Genome. Startup Genome’s Global Startup Ecosystem Report ranked more than 275 regional ecosystems based on factors like startup growth and activity, innovation and research, capital availability, talent and support for companies. Silicon […]

Read More

Navrogen Enters Into CRADA With USAMRIID To Test Proprietary Small Molecule NK Cell Activators Against SARS-COV-2 Infection

September 16, 2021

Navrogen, Inc., a privately held preclinical biotechnology company, announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with researchers at The United States Army Medical Research Institute of Infectious Diseases (USAMRIID). The CRADA is focused on testing Navrogen’s small molecule NK cell activating agents on suppressing propagation of SARS-COV-2. Researchers […]

Read More

Centers for Medicare & Medicaid Services Issues New Code for Encala®

September 1, 2021

Envara Health, a company committed to making significant advancements in the field of clinical nutrition, today announced that the Centers for Medicare and Medicaid Services (CMS) has issued a new Healthcare Common Procedure Coding System (HCPCS) code for Encala®, a structured lipid matrix powder for oral administration. This decision establishes the S9432 code, “Medical Food […]

Read More

Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV

August 30, 2021

Excision BioTherapeutics Inc, the developer of CRISPR-based therapies intended to cure viral infectious diseases, today announced that the Temple University team collaborating with Excision on a project, CRISPR for Cure, has received a Martin Delaney Grant from the National Institutes of Health (NIH) of $4.8 million on an annual basis for the next five years […]

Read More

Biomeme & Predigen Merge to Enable Point-of-Care Delivery of Host Response Tests That Address Critical Unmet Needs in Healthcare

August 27, 2021

Biomeme, the leading provider of portable PCR testing solutions, has signed a definitive agreement to acquire Predigen, a privately held diagnostic company and emerging leader in precision medicine focused on host response diagnostics. Predigen’s acquisition will expand Biomeme’s capabilities across infectious disease and clinical microbiology, business management, and commercialization. redigen’s portfolio includes flagship host gene […]

Read More

NeuroFlow Targets ‘Sweet Spot’ for Growth by Working with Value-Based Health Care Clients

August 13, 2021

Mental health startup NeuroFlow is looking at health systems pursuing value-based payment models as an avenue for growth. NeuroFlow sees an opportunity to expand its reach through health systems that are using value-based reimbursement plans, which focus on better health outcomes rather than being paid for specific services, Chief Operating Officer Adam Pardes said. The […]

Read More

Navrogen Announces The Closing Of $3.2M Funding To Support Its Humoral Immuno-Oncology Platform Discovery Technologies And Preclinical Pipeline

August 10, 2021

Navrogen, Inc. announced today that it has raised $3.2M in convertible note financing to support its operations, Humoral Immuno-Oncology (HIO) discovery platform and preclinical therapeutic pipeline activities. The financing was led by Ben Franklin Technology Partners of South Eastern Pennsylvania and a number of private investors. Previous clinical studies have confirmed that tumors produce immune […]

Read More

5 Years of ImpactPHL Ventures: ‘Big Change can be Enabled with Key, Early Investments’

August 2, 2021

In 2016, Philadelphia’s economy was doing well by many traditional measures, boasting nine consecutive years of population growth, declining unemployment, increasing levels of educated residents, and a growing national reputation as a startup and technology hub. Ben Franklin Technology Partners, having invested $200 million in more than 2,000 companies generating more than 32,000 jobs since […]

Read More

PolyCore Therapeutics Awarded Supplemental NINDS Grant to Understand the Effects of its Lead Compound, PCT-3012, to Treat Cognitive Impairment in Alzheimer’s disease

May 17, 2021

PolyCore Therapeutics LLC, a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced that it has been awarded a $456,000 Phase II SBIR supplemental grant from the National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH) to fund research of […]

Read More

Next